Key result
Cardiac pacemakers have evolved beyond conventional antibradycardic therapy to include novel diagnostic functions, telemonitoring, autoadjustment of parameters, and cardiac resynchronization therapy.
Answers are grounded in this paper and cite their sources.
This review highlights recent technological advancements in cardiac pacemakers, including telemonitoring, autoadjustment, and novel pacing algorithms.
With increasing advances in technology, cardiac pacemakers have become highly sophisticated devices that allow diagnostic and therapeutic functions beyond conventional antibradycardic therapy. This review discusses the most promising developments in antibradycardic device therapy, such as novel diagnostic functions, telemonitoring, autoadjustment of programmed parameters, algorithms for support of intrinsic atrioventricular conduction, pacing algorithms for the prevention of atrial arrhythmias and cardiac resynchronization therapy. A short overview of the basic principles of antibradycardic device therapy is also provided.
No takes yet. Share an insight, caveat, or question.
Mortensen et al. (2007) conducted a review in Bradycardia. Antibradycardic devices was evaluated. Cardiac pacemakers have evolved beyond conventional antibradycardic therapy to include novel diagnostic functions, telemonitoring, autoadjustment of parameters, and cardiac resynchronization therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: